GGG

GENOMTEC

No trades
See on Supercharts
Market capitalization
‪113.93 M‬PLN
−0.88PLN
‪−9.01 M‬PLN
‪1.00 K‬PLN
Beta (1Y)
0.06
Employees (FY)
17
Change (1Y)
+1 +6.25%
Revenue / Employee (1Y)
14.92PLN
Net income / Employee (1Y)
‪−134.45 K‬PLN

About GENOMTEC


CEO
Miron Tokarski
Headquarters
Wroclaw
Founded
2016
ISIN
PLGNMTC00017
FIGI
BBG00ZNLD9P9
Genomtec SA engages in the research and development of molecular diagnostic equipment. It offers mobile molecular analyzer. The company was founded by Miron Tokarski, Malgorzata Malodobra-Mazur, and Henryk Roguszczak in December 2016 and is headquartered in Wroclaw, Poland.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of GMT is 8.37 PLN — it has decreased by −1.87% in the past 24 hours. Watch GENOMTEC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GPW exchange GENOMTEC stocks are traded under the ticker GMT.
GMT stock has fallen by −1.99% compared to the previous week, the month change is a 14.62% rise, over the last year GENOMTEC has showed a −26.90% decrease.
GMT reached its all-time high on Mar 22, 2021 with the price of 23.90 PLN, and its all-time low was 4.31 PLN and was reached on Oct 13, 2022. View more price dynamics on GMT chart.
See other stocks reaching their highest and lowest prices.
GMT stock is 6.00% volatile and has beta coefficient of 0.06. Track GENOMTEC stock price on the chart and check out the list of the most volatile stocks — is GENOMTEC there?
Today GENOMTEC has the market capitalization of ‪113.92 M‬, it has increased by 2.56% over the last week.
Yes, you can track GENOMTEC financials in yearly and quarterly reports right on TradingView.
GMT net income for the last quarter is ‪−3.38 M‬ PLN, while the quarter before that showed ‪−2.66 M‬ PLN of net income which accounts for −27.24% change. Track more GENOMTEC financial stats to get the full picture.
No, GMT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 5, 2024, the company has 17.00 employees. See our rating of the largest employees — is GENOMTEC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GENOMTEC EBITDA is ‪−11.07 M‬ PLN, and current EBITDA margin is ‪−890.80 K‬%. See more stats in GENOMTEC financial statements.
Like other stocks, GMT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENOMTEC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GENOMTEC technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GENOMTEC stock shows the sell signal. See more of GENOMTEC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.